Half-year report · HY
150A.TEDINET S100X2KU
Period2025-04-01 → 2025-09-30
Filed2025-11-12
StandardJapan GAAP
ConsolidatedYes
Data checks11 of 11 passed
Key figures · 30
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.2bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥4.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Operating income | −¥121m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Ordinary income | −¥121m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥185m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | −¥121m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥101m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥144m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | −¥109m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Total assets | ¥3.6bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥3.0bn | at 2025-03-31 | Cons. | Assets |
| Total liabilities | ¥1.7bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥944m | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥2.0bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2025-03-31 | Cons. | Net assets |
| Cash and deposits | ¥1.0bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥811m | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.0bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥811m | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥38m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥138m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥408m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥691m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥644m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥168m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥-17.78 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥25.67 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥25.22 | 2024-04-01 → 2025-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 53.9% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.3% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 22
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2025-04-01 → 2025-09-30 | ¥42m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2025-04-01 → 2025-09-30 | ¥33m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥8m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2025-04-01 → 2025-09-30 | −¥32m |
| Reconciling Itemsreconciling | revenue | 2025-04-01 → 2025-09-30 | −¥9m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-04-01 → 2025-09-30 | −¥9m |
| Reconciling Itemsreconciling | segment profit | 2025-04-01 → 2025-09-30 | −¥315m |
| Home Care Medicine Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥697m |
| Home Care Medicine Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥696m |
| Home Care Medicine Businessreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Home Care Medicine Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | −¥45m |
| Regional Revitalization Businessreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Regional Revitalization Businessreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥1.5bn |
| Regional Revitalization Businessreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥271m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥226m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥9m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥194m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 363
| Item | Context | Value | Unit |
|---|---|---|---|
| Type1 semi annual consolidated statement of comprehensive income (text) | InterimDuration | Text · Plus | |
| Type1 semi annual consolidated statement of cash flows (text) | InterimDuration | Text · Plus | |
| Major components of selling general and administrative expenses (text) | InterimDuration | Text · Plus | |
| Reconciliation of ending balance of cash and cash equivalents with account balances per balance sheet (text) | InterimDuration | Text · Plus | |
| Notes regarding dividend (text) | InterimDuration | Text · Plus | |
| Notes when there is significant changes in amounts of equity (text) | InterimDuration | Text · Plus | |
| Notes segment information etc type1 semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Footnotes regarding segment information table (text) | InterimDuration | Text · Plus | |
| Information about impairment loss of non current assets or goodwill etc for each reportable segment (text) | InterimDuration | Text · Plus | |
| Notes revenue recognition semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Notes per share information semi annual consolidated financial statements (text) | InterimDuration | Text · Plus | |
| Other information consolidated financial statements etc (text) | InterimDuration | Text · Plus | |
| Information about company which provides guarantee to reporting company (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 11 of 11 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |